Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2005-11-20 22:13:26 UTC |
---|
Update Date | 2021-09-14 15:44:42 UTC |
---|
HMDB ID | HMDB0001786 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ethenodeoxyadenosine |
---|
Description | Etheno nucleosides are a new class of chemically modified components of nucleic acids. These base-modified nucleosides demonstrate significant biological properties, acting, among others, as antiviral or antitumor agents. One of the possible modifications of the nucleoside is their transformation into ethenonucleosides. Thus, nucleosides or their respective heterocyclic bases, possessing an exocyclic amino group, as well as a neighboring endocyclic nitrogen, can react with some bifunctional reagents (e.g., α-halocarbonyl compounds) to form products with an additional five-membered ring of the imidazole type. The ethenonucleosides basically do not occur in nature; some of the only exceptions are Y-nucleosides. Etheno modified DNA bases are generated from the carcinogens vinyl chloride and urethane, but also by reactions of DNA with products derived from lipid peroxidation (LPO) and oxidative stress via endogenous pathways. Highly variable background levels of epsilon-adducts were detected in DNA from different organs of unexposed humans and rodents. Several known cancer risk factors increased the level of these DNA lesions in target organs: elevated epsilon-adducts were found in hepatic DNA from patients with metal storage diseases, after overproduction of nitric oxide (NO) by inducible NO synthase (iNOS) in a mouse model, and in colonic polyps of familial adenomatous polyposis patients. A high omega-6-polyunsaturated fatty acid diet increased epsilon-DNA adducts in white blood cells of female subjects. (PMID:10882861 ). |
---|
Structure | OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CN1C=CN=C21 InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9+/m0/s1 |
---|
Synonyms | Value | Source |
---|
1,N(6)-Deoxyethenoadenosine | MeSH | 1,N(6)-Ethenodeoxyadenosine | MeSH | 1,N2-Etheno-2'-deoxyguanosine | MeSH | 1,N6-Etheno-2'-deoxyadenosine | MeSH | 2'-Deoxy-2-deuteroethenoadenosine | MeSH | 1,N6-etheno-DA | HMDB | 1,N6-Ethenodeoxyadenosine | HMDB | N1,N6-etheno-2'-Deoxyadenosine | HMDB |
|
---|
Chemical Formula | C12H13N5O3 |
---|
Average Molecular Weight | 275.2633 |
---|
Monoisotopic Molecular Weight | 275.101839307 |
---|
IUPAC Name | (2R,3S,5R)-2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolan-3-ol |
---|
Traditional Name | ethenodeoxyadenosine |
---|
CAS Registry Number | 68498-25-9 |
---|
SMILES | OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CN1C=CN=C21 |
---|
InChI Identifier | InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9+/m0/s1 |
---|
InChI Key | XQQIMTUYVDUWKJ-DJLDLDEBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as purines and purine derivatives. These are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Imidazopyrimidines |
---|
Sub Class | Purines and purine derivatives |
---|
Direct Parent | Purines and purine derivatives |
---|
Alternative Parents | |
---|
Substituents | - Purine
- N-substituted imidazole
- Pyrimidine
- Heteroaromatic compound
- Tetrahydrofuran
- Imidazole
- Azole
- Secondary alcohol
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ethenodeoxyadenosine,1TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC3=C2N=CN2C=CN=C32)C[C@@H]1O | 2871.0 | Semi standard non polar | 33892256 | Ethenodeoxyadenosine,1TMS,isomer #2 | C[Si](C)(C)O[C@H]1C[C@H](N2C=NC3=C2N=CN2C=CN=C32)O[C@@H]1CO | 2870.0 | Semi standard non polar | 33892256 | Ethenodeoxyadenosine,2TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC3=C2N=CN2C=CN=C32)C[C@@H]1O[Si](C)(C)C | 2871.5 | Semi standard non polar | 33892256 | Ethenodeoxyadenosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC3=C2N=CN2C=CN=C32)C[C@@H]1O | 3086.1 | Semi standard non polar | 33892256 | Ethenodeoxyadenosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1C[C@H](N2C=NC3=C2N=CN2C=CN=C32)O[C@@H]1CO | 3087.4 | Semi standard non polar | 33892256 | Ethenodeoxyadenosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC3=C2N=CN2C=CN=C32)C[C@@H]1O[Si](C)(C)C(C)(C)C | 3292.3 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ethenodeoxyadenosine GC-MS (Non-derivatized) - 70eV, Positive | splash10-054o-9170000000-59787ef95e13965a6f74 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethenodeoxyadenosine GC-MS (2 TMS) - 70eV, Positive | splash10-0v4i-9855100000-1aa19e03cd5abf43bec2 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethenodeoxyadenosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Ethenodeoxyadenosine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004i-0090000000-1cbcf897b8d539f74c9d | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ethenodeoxyadenosine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-03di-0900000000-7351b3ecaf69532e4ae9 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ethenodeoxyadenosine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-03di-1900000000-cea99433c51ea3b57b8c | 2012-07-24 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 10V, Positive-QTOF | splash10-03di-0920000000-4723a3e7bccfd3fb82a3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 20V, Positive-QTOF | splash10-03di-0900000000-319e0450fd20aa8b295f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 40V, Positive-QTOF | splash10-03di-0900000000-123c329a87834ac8c719 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 10V, Negative-QTOF | splash10-00di-0290000000-8d53e894625170dfa26f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 20V, Negative-QTOF | splash10-0a4i-0910000000-c8a7d5a2ae45462ace75 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 40V, Negative-QTOF | splash10-0a4i-0900000000-944674f1809414d8aa98 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 10V, Positive-QTOF | splash10-03di-0900000000-491bffd5eb2009008d64 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 20V, Positive-QTOF | splash10-03di-0900000000-491bffd5eb2009008d64 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 40V, Positive-QTOF | splash10-03di-0900000000-d0145665222b050d7b7c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 10V, Negative-QTOF | splash10-00di-0190000000-bf4918a4b52f776c05be | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 20V, Negative-QTOF | splash10-0a4i-0900000000-9997b969fd66d57e3889 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethenodeoxyadenosine 40V, Negative-QTOF | splash10-0a4i-0900000000-614f89543dcac00da239 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 5%_DMSO, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
General References | - Hanaoka T, Nair J, Takahashi Y, Sasaki S, Bartsch H, Tsugane S: Urinary level of 1,N(6) -ethenodeoxyadenosine, a marker of oxidative stress, is associated with salt excretion and omega 6-polyunsaturated fatty acid intake in postmenopausal Japanese women. Int J Cancer. 2002 Jul 1;100(1):71-5. [PubMed:12115589 ]
- Hillestrom PR, Nyssonen K, Tuomainen TP, Pukkala E, Salonen JT, Poulsen HE: Urinary excretion of epsilondA is not predictive of cancer development: a prospective nested case-control study. Free Radic Res. 2005 Jan;39(1):51-3. [PubMed:15875811 ]
- Bartsch H, Nair J: New DNA-based biomarkers for oxidative stress and cancer chemoprevention studies. Eur J Cancer. 2000 Jun;36(10):1229-34. [PubMed:10882861 ]
|
---|